Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05766189 · ClinicalTrials.gov registry record · NA
Wastewater Surveillance to Boost COVID-19 Vaccine Uptake
A NA study, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 100,000
- Enrollment target
NCT05766189: Completed NA study, sponsored by Syracuse University.
NCT05766189 is a NA study that has completed, run by Syracuse University. The registered enrollment target is 100,000 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7033% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05766189, a NA study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100,000 participants
- Enrollment target
Study Summary
The goal of the study is to determine the effect of a communications campaign sharing wastewater surveillance data to influence vaccine uptake in a metropolitan and non-metropolitan environment. The study will be conducted in Onondaga and Cayuga counties in New York State. Individuals of all ages within the selected counties, located in metropolitan and non-metropolitan environments will receive the intervention. The evaluation study design is a comparison-control trial. The primary outcome measure is the proportion of vaccine-eligible individuals in the county that received the COVID-19 vaccine stratified by type of vaccine dosage and age group. Vaccination data will be aggregated to the county by the State Department of Health and shared with the research team. Wastewater data will be pulled from the wastewater surveillance network. A difference in differences analysis will be used to estimate the effect of the intervention on both the outcomes between intervention and comparison groups following the intervention, while adjusting for potential confounding factors.
Primary Outcome
Number of individuals receiving a booster COVID-19 vaccine
Interventions
- BEHAVIORAL Wastewater vaccine prompts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT05766189 record still lists
NCT05766189 is an interventional study that assigns participants to a tested intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7033% higher).
The record links to 0 conditions, and to 1 intervention - of which Wastewater vaccine prompts is the first listed.
NCT05766189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05766189 about?
NCT05766189 is a clinical study titled "Wastewater Surveillance to Boost COVID-19 Vaccine Uptake". The goal of the study is to determine the effect of a communications campaign sharing wastewater surveillance data to influence vaccine uptake in a metropolitan and non-metropolitan environment. The study will be conducted in Onondaga and Cayuga counties in New York State. Individuals of all ages wi...
What is the current status of trial NCT05766189?
This trial is currently completed. It is a NA study. The enrollment target is 100,000 participants. The study started on 2023-03-01. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05766189?
The interventions under investigation include: Wastewater vaccine prompts (BEHAVIORAL).
Who is sponsoring clinical trial NCT05766189?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05766189's enrollment target sits among peer trials
100,000 3rd of 2000 higher than 1,998 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI